RecipharmCobra Biologics, in collaboration with the Royal Holloway, University of London and the Universita Cattolica del Sacro Cuore of Rome, Italy, has released the results of a study to develop an oral vaccine against tuberculosis. The study showed that the orally delivered ORT-VAC DNA vaccine produced higher immune responses in mice than the injected DNA vaccine, resulting in a reduction of the TB bacterium Mycobacterium tuberculosis in the lungs of immunized mice. Previous studies in mic...